These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2971411)

  • 1. Significance of atrial natriuretic factor in chronic heart failure.
    McMurray J; Struthers AD
    Br J Hosp Med; 1988 Jul; 40(1):55-7. PubMed ID: 2971411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic application of atrial natriuretic peptide for congestive heart failure].
    Harada M; Nakao K
    Nihon Rinsho; 2007 May; 65 Suppl 5():115-9. PubMed ID: 17571375
    [No Abstract]   [Full Text] [Related]  

  • 3. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic application of ANP: past and future].
    Saito Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():139-46. PubMed ID: 15506358
    [No Abstract]   [Full Text] [Related]  

  • 5. [Auricular natriuretic factor].
    Gamba G; Peña JC
    Rev Invest Clin; 1987; 39(1):81-92. PubMed ID: 2955494
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.
    Chee KH; Amudha K; Hussain NA; Haizal HK; Choy AM; Lang CC
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):140-8. PubMed ID: 14608517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial natriuretic peptide for therapy of heart failure].
    Takeda N
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):270-5. PubMed ID: 15768591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F; Guardigli G; Cappelli M; Bernardi P
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experiences with atrial natriuretic factor].
    Brunner HR; Biollaz J; Waeber B; Nussberger J
    Schweiz Med Wochenschr; 1987 Dec; 117(49):1937-40. PubMed ID: 2962282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human atrial natriuretic peptide: a secretory product of the heart and its significance for physiology and clinical practice].
    Vierhapper H; Waldhäusl W
    Wien Klin Wochenschr; 1987 Mar; 99(5):133-8. PubMed ID: 2953110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a clinical indication for the determination of atrial natriuretic peptide?].
    Reiss U; Stimpel M
    Schweiz Rundsch Med Prax; 1993 Jul; 82(27-28):755-8. PubMed ID: 8346382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral endopeptidase 24.11: a modulator of natriuretic peptides.
    Margulies KB; Burnett JC
    Semin Nephrol; 1993 Jan; 13(1):71-7. PubMed ID: 8434188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atrial natriuretic factor in cardiovascular diseases].
    Nakamura M; Arakawa N; Hiramori K
    Kokyu To Junkan; 1991 Oct; 39(10):971-8. PubMed ID: 1836068
    [No Abstract]   [Full Text] [Related]  

  • 20. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.